Sex differences in PPARγ expressions in rat adipose tissues

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 4, 2007, Pages 818-820

  Kadowaki, Kyoko ^a   Fukino, Katsumi ^a   Negishi, Etsuko ^a   Ueno, Koichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Adipose tissue; Estrous cycle; Peroxisome proliferator activated receptor (PPAR) ; Sex difference

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTIBODY; PIOGLITAZONE; RECEPTOR ANTIBODY; SEX HORMONE; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIESTRUS; ESTRUS CYCLE; FEMALE; GONAD; HORMONE SENSITIVITY; MALE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SUBCUTANEOUS FAT; VAGINA SMEAR; WESTERN BLOTTING; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; ESTRUS; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; DIESTRUS; ESTRUS; FEMALE; GENE EXPRESSION; MALE; PPAR GAMMA; RATS; RATS, WISTAR; SEX FACTORS;

EID: 34147180133     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.818     Document Type: Article

References (22)

1. Chawla A., Schwarz E. J., Dimaculangan D. D., Lazar M. A., Endocrinology, 135, 798-800 (1994).
2. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M., Genes Dev., 8, 1324-1334 (1994).
3. Ren D., Collingwood T. N., Rebar E. J., Wolffe A. P., Camp H. S., Genes Dev., 16, 27-32 (2002).
4. A commentary of "precautions for use" of Actos (Takeda Pharmaceutical Co., Ltd.).
5. Fujita Y., Yamada Y., Kusama M., Yamauchi T., Kamon J., Kadowaki T., Iga T., Comp. Biochem. Physiol. C, Toxicol. Pharmacol., 136, 85-94 (2003).
6. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., J. Biol. Chem., 270, 12953-12956 (1995).
7. Dieudonné M. N., Leneveu M. C., Giudicelli Y., Pecquery R., Am. J. Physiol. Cell Physiol., 286, C655-C661 (2004).
8. Dieudonne M. N., Pecquery R., Leneveu M. C., Giudicelli Y., Endocrinology, 141, 649-656 (2000).
9. Kajita K., Ishizuka T., Mune T., Miura A., Ishizawa M., Kanoh Y., Kawai Y., Natsume Y., Yasuda K., Endocrinology, 144, 253-259 (2003).
10. Singh R., Artaza J. N., Taylor W. E., Braga M., Yuan X., Gonzalez-Cadavid N. F., Bhasin S., Endocrinology, 147, 141-154 (2006).
11. Sugiyama E., Iga T., Biomed. Therap., 37, 432-434 (2003).
12. Cooper R. L., Goldman J. M., Vandenbergh J. G., "Female Reproductive Toxicology-Methods in Toxicology," 3B, Academic Press, San Diego, 1993, pp. 45-56.
13. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A. M., Saladin R., Najib J., Laville M., Fruchart J. C., Deeb S., Vidal-Puig A., Flier J., Briggs M. R., Staels B., Vidal H., Auwerx J., J. Biol. Chem., 272, 18779-18789 (1997).
14. Yanase T., Yashiro T., Takitani K., Kato S., Taniguchi S., Takayanagi R., Nawata H., Biochem. Biophys. Res. Commun., 233, 320-324 (1997).
15. Vidal-Puig A. J., Considine R. V., Jimenez-Linan M., Werman A., Pories W. J., Caro J. F., Flier J. S., J. Clin. Invest., 99, 2416-2422 (1997).
16. Giusti V., Verdumo C., Suter M., Gaillard R. C., Burckhardt P., Pralong F., Diabetes, 52, 1673-1676 (2003).
17. Rodríguez E., Ribot J., Rodríguez A. M., Palou A., Obes. Res., 12, 1455-1463 (2004).
18. Price T. M., O'Brien S. N., J. Clin. Endocrinol. Metab., 77, 1041-1045 (1993).
19. Pedersen S. B., Bruun J. M., Hube F., Kristensen K., Hauner H., Richelsen B., Mol. Cell Endocrinol., 182, 27-37 (2001).
20. Wade G. N., Gray J. M., Endocrinology, 103, 1695-1701 (1978).
21. Dieudonne M. N., Pecquery R., Boumediene A., Leneveu M. C., Giudicelli Y., Am. J. Physiol., 274, C1645-C1652 (1998).
22. O'Brien S. N., Welter B. H., Mantzke K. A., Price T. M., J. Clin. Endocrinol. Metab., 83, 509-513 (1998).